Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/26/1998EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
08/26/1998EP0859635A1 Stabilised pharmaceutical compositions containing dobutamine
08/26/1998EP0859634A1 Pharmaceutical compositions containing platelet aggregation inhibitors
08/26/1998EP0859631A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins
08/26/1998EP0859630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
08/26/1998EP0859629A2 Product for inhibition of attachment of h. influenzae to human cells
08/26/1998EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
08/26/1998EP0859627A1 Mimicking peptides in cancer therapy
08/26/1998EP0859626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation
08/26/1998EP0859624A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES
08/26/1998EP0859623A1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves
08/26/1998EP0859621A1 Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
08/26/1998EP0859620A1 Nitrogen monoxide composition for use as a drug
08/26/1998EP0859619A1 Multiple vitamin supplement composition
08/26/1998EP0859617A1 Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
08/26/1998EP0859616A1 Topical composition containing capsazepine
08/26/1998EP0859615A1 Carbostyril derivative for curing ophthalmological diseases
08/26/1998EP0859614A1 Rotamase enzyme activity inhibitors
08/26/1998EP0859613A2 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
08/26/1998EP0859612A2 Novel composition containing an acid-labile omeprazole and process for its preparation
08/26/1998EP0859611A1 Enhancement of erectile function with renin-angiotensin system inhibitors
08/26/1998EP0859610A1 Ibogamine congeners
08/26/1998EP0859609A1 Topical liquid composition, method for preparing same and uses thereof
08/26/1998EP0859608A1 Treating niddm with rxr agonists
08/26/1998EP0859607A1 Guanidino protease inhibitors
08/26/1998EP0859605A1 Transdermal therapeutic system (tts) for administering active substances for the treatment of drug dependency or drug addiction
08/26/1998EP0859603A1 Sustained release matrix for high-dose insoluble drugs
08/26/1998EP0859601A2 Prolonged release of gm-csf
08/26/1998EP0859600A1 New technology for wet granulation
08/26/1998EP0859599A1 Liposomal formulations of mitoxantrone
08/26/1998EP0859598A1 Liposomes containing a corticosteroid
08/26/1998EP0859596A2 Gel formulations containing growth factors
08/26/1998EP0859595A1 Therapeutic preparation for the transdermal administration of active substances
08/26/1998EP0859592A1 Skin-care agent for ageing skin
08/26/1998EP0859591A1 Use of at least one no synthase inhibitor for treating sensitive skin
08/26/1998EP0767787B1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
08/26/1998EP0764155B1 Taxoids, preparation and pharmaceutical compositions containing them
08/26/1998EP0741715B1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/26/1998EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists
08/26/1998EP0697861B1 Oral compositions containing triclosan for the treatment of aphthous ulcers
08/26/1998EP0686641B1 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug
08/26/1998EP0674622B1 Tetrahydrocarbazole derivatives as 5-ht1-like agonists
08/26/1998EP0673360B1 Aminomethylindans, -benzofuranes and -benzothiophenes
08/26/1998EP0668874B1 Lhrh antagonists and intermediate products
08/26/1998EP0664708B1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
08/26/1998EP0656015B1 New nimesulide salt cyclodextrin inclusion complexes
08/26/1998EP0558603B1 Retroviral protease inhibitors
08/26/1998EP0531413B1 An antiviral composition containing prostratin
08/26/1998CN1191572A Recombinant protein having bacteriophage endosialidase enzymatic activity
08/26/1998CN1191567A Macrophage activating factors derived from cloned vitamin D binding protein
08/26/1998CN1191553A Method of detecting lung disease
08/26/1998CN1191543A Meiosis regulating compounds
08/26/1998CN1191542A Nor-pregnanes for inducing hypothalamic effects
08/26/1998CN1191537A Antiparasitic marcfortines and paraherquamides
08/26/1998CN1191535A Medicine composition and use thereof
08/26/1998CN1191534A Oxazolidinone derivs, their preparation and therapeutical use
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/26/1998CN1191531A N-hydroxyureas as antiinflammatory agents
08/26/1998CN1191530A Manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysts for dismutating superoxide
08/26/1998CN1191492A Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/26/1998CN1191491A 结缔组织生长因子 Connective tissue growth factor
08/26/1998CN1191489A Endoparasiticidal composition
08/26/1998CN1191488A Use of calendula glycosides for treatment of psoriasis
08/26/1998CN1191487A Method for inhibiting vascular smooth muscle cell migration
08/26/1998CN1191486A Use of unsubstd and substd. N-(pyrrol-1-yl) pyridinamines as anticonvulsant agents
08/26/1998CN1191485A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substd. amino 1, 2, 3-triazoles
08/26/1998CN1191484A Melatonin agonists for treating benign prostatic hyperplasia
08/26/1998CN1191483A Use of ipriflavone to reduce number of CD8 + cells
08/26/1998CN1191482A Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substd.) hydrazines
08/26/1998CN1191481A Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
08/26/1998CN1191475A Drug delivery compositions for improved stability of steroids
08/26/1998CN1191219A Melatonin deriv, its preparation, producing process and use thereof in pharmaceutics
08/26/1998CN1191217A N(1), N(2)-di (2,3-dihydroxy-4,6-disulfobenzyl) ethylene diamine chelant
08/26/1998CN1191113A Antimalarial compound naphtholquine
08/26/1998CN1191112A Skin protecting antichapping cream
08/26/1998CN1191111A Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient
08/26/1998CN1191073A Dihaloformaldoxime carbamates as antimicrobial agents
08/26/1998CN1039586C Method for preparing organic salts of N, N'-diacetyl cystine
08/26/1998CN1039585C Pleuromutilin deriv. and cyclodextrin complexes and pharmaceutic preparation contg. same
08/26/1998CN1039570C Preparation method of artificial mucus for lubricating body cavity
08/26/1998CA2230349A1 Sulfonamide-substituted fused 7-membered ring compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them
08/26/1998CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence
08/25/1998US5798491 Multi-mechanistic chemical cleavage using certain metal complexes
08/25/1998US5798393 Betaxolol hydrochloride for the treatment of anxiety disorders
08/25/1998US5798392 Sulfonyl fluorides for the treatment of Alzheimer's disease
08/25/1998US5798391 Viricides, antitubercular agents
08/25/1998US5798390 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
08/25/1998US5798389 Administering docosahexaenoic acid and it's derivative for treating autoimmune disease, kidney disorder and side effect reduction
08/25/1998US5798388 Method and composition for treating mammalian diseases caused by inflammatory response
08/25/1998US5798386 Angiogenic lipid formulations
08/25/1998US5798383 Prevention of an inflammatory disease, allergy or cardiovascular disease for which a 5-lipoxygenase inhibitor is needed
08/25/1998US5798380 Administering latrunculin a to enhance aqueous humor outflow in eye
08/25/1998US5798378 Treatment of ocular hypertension
08/25/1998US5798375 Treatment of arteriosclerosis and xanthoma
08/25/1998US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
08/25/1998US5798372 Method for preventing onset of restenosis after angioplasty employing a retinoid
08/25/1998US5798371 L-threonine and vitamin b6
08/25/1998US5798370 Anticoagulants
08/25/1998US5798369 Glaucoma treatment
08/25/1998US5798367 Indazolecarboxamides
1 ... 6616 6617 6618 6619 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 6636 ... 7860